Fig. 1 · Structure
Documents & Downloads
KSG-504 anhydrous
CCK Receptor Antagonist
KSG-504 anhydrous is a potent antagonist of the cholecystokinin (CCK) receptor. This compound has been shown to inhibit Ethionine-induced acute pancreatitis in rat models, demonstrating its relevance in studying pancreatic function and pathology. Additionally, KSG-504 facilitates the regeneration of acinar cells, making it a valuable tool for investigating therapeutic strategies in pancreatic diseases.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 137005-17-5 |
| Applications | CCK Receptor Antagonist |
| Formula | C31H49N5O8S |
| Molecular Weight | 651.81 |
| SMILES | N=C(N)NCCC[C@H](N)C(O)=O.CCCCCN(CCCOC)C([C@@H](CCC(O)=O)CS(=O)(C1=CC2=C(C=CC=C2)C=C1)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.